Trials / Conditions / Resectable Esophageal Cancer

Resectable Esophageal Cancer

7 registered clinical trials studyying Resectable Esophageal Cancer — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC NCT07385664	Ji Yongling	Phase 2
Recruiting	Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Bl NCT06649474	University Hospital, Clermont-Ferrand	N/A
Active Not Recruiting	Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection NCT05307835	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 1
Unknown	Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer NCT04006041	Jianhua Fu	Phase 2
Completed	Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer NCT03490292	University of Wisconsin, Madison	Phase 1 / Phase 2
Completed	Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer NCT01858805	Universitätsklinikum Hamburg-Eppendorf	—
Terminated	Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcin NCT00827671	P.O. Witteveen	Phase 2